Omicron Unlikely to Cause Severe Illness, BioNTech Founder Says
By The Wall Street Journal
30/11/21·1m 38s
But Moderna CEO says current vaccines could be less effective against Omicron. FDA moving to authorize Pfizer-BioNTech boosters for 16-, 17-year-olds. Federal Reserve to consider speedier reduction of asset purchases. U.K. competition regulator tells Facebook parent Meta to sell Giphy. Trenae Nuri reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices